Literature DB >> 17443728

Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy.

Francesca Erroi1, Marco Scarpa, Imerio Angriman, Attilio Cecchetto, Lara Pasetto, Eleonora Mollica, Marina Bettiol, Cesare Ruffolo, Lino Polese, Umberto Cillo, Davide F D'Amico.   

Abstract

BACKGROUND: Ovarian metastases from primary colorectal cancer occur in 3-8% of female patients. The aim of this study was to assess the prognostic value of radical oophorectomy for ovarian metastasis from colorectal cancer. PATIENTS AND METHODS: From our series of 859 patients operated for colorectal cancer from 1982 to 2005 ten patients with isolated ovarian metastasis were retrieved. Ovarian colorectal metastasis diagnosis was confirmed by pathology revision. Overall and disease-free survival after radical oophorectomy for metastases were assessed and compared with literature data.
RESULTS: The median follow-up from ovarian metastases resection was 36 months (range 194-14). Survival analysis showed that survival rate after ovarian metastasectomy was 100% at 1 year and 80% at 5 years of follow up.
CONCLUSION: Our study, although limited by a relatively short follow-up and small sample size, shows that bilateral oophorectomy for ovarian metastasis from colorectal cancer has a good impact on disease-free and overall survival.

Entities:  

Mesh:

Year:  2007        PMID: 17443728     DOI: 10.1002/jso.20803

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  25 in total

1.  Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Authors:  Manabu Shimomura; Masazumi Okajima; Takao Hinoi; Hiroyuki Egi; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Tomohiro Adachi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2012-03-10       Impact factor: 2.571

Review 2.  Unusual osseous metastases from rectal adenocarcinoma: a case report and review of the literature.

Authors:  T M Connelly; R P Piggott; R M Waldron; P O'Grady
Journal:  J Gastrointest Surg       Date:  2015-02-27       Impact factor: 3.452

Review 3.  Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

Authors:  Atsuya Takeda; Naoko Sanuki; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  Prognosis and factors affecting colorectal cancer with ovarian metastasis.

Authors:  Fangyue Zhou; Jingxin Ding
Journal:  Updates Surg       Date:  2021-02-01

5.  Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Authors:  Gozde Kir; Ayse Gurbuz; Ates Karateke; Mustafa Kir
Journal:  World J Gastrointest Surg       Date:  2010-04-27

6.  Surgical Resection of Colorectal Cancer With Distant Metastases to Other than Liver or Lung.

Authors:  Atsushi Naito; Yoshinori Kagawa; Kenji Kawai; Atsushi Takeno; Yutaka Takeda; Masahisa Ohtsuka; Yozo Suzuki; Mitsunobu Imasato; Yujiro Fujie; Hiroyuki Nakaba; Hiroki Akamatsu; Kohei Murata
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

7.  Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center.

Authors:  Kian-Lee Tan; Wah-Siew Tan; Jit-Fong Lim; Kong-Weng Eu
Journal:  Int J Colorectal Dis       Date:  2009-08-25       Impact factor: 2.571

8.  Clinical characteristics and prognostic analysis of Krukenberg tumor.

Authors:  Fang Wu; Xiaoai Zhao; Baibing Mi; L U Feng; N A Yuan; Fuxi Lei; Min Li; Xinhan Zhao
Journal:  Mol Clin Oncol       Date:  2015-09-02

9.  Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis.

Authors:  Stijn Crobach; Tom van Wezel; Hans F Vasen; Hans Morreau
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

10.  Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients.

Authors:  Wenhua Li; Huaying Wang; Jian Wang; Fangfang L V; Xiaodong Zhu; Zhonghua Wang
Journal:  BMC Cancer       Date:  2012-07-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.